Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€204.10

€204.10

-1.080%
-2.2
-1.080%
€289.40
 
14.11.25 / Tradegate WKN: 856584 / Symbol: HUM / Name: Humana / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Humana Inc. Stock

A loss of -1.080% shows a downward development for Humana Inc..
Humana Inc. is currently one of the favorites of our community with 14 Buy predictions and no Sell predictions.
As a result the target price of 289 € shows a positive potential of 41.6% compared to the current price of 204.1 € for Humana Inc..
For the coming years our community has positive and negative things to say abot the Humana Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Humana Inc. (Symbol: HUM) is a leading healthcare and wellness company headquartered in Louisville, Kentucky, specializing in offering a diversified range of health insurance, wellness programs, and managed care plans to individual, group, government, and military customers. With a strong commitment to providing personalized, affordable, and high-quality healthcare solutions, Humana emphasizes on simplifying access and meeting the evolving needs of its vast clientele through leveraging data analytics, technology, and innovation. As a publicly traded entity, Humana’s stock is listed on the New York Stock Exchange, and it forms part of the esteemed S&P 500 index, reflecting its significant impact and presence within the highly competitive healthcare sector.

Pros and Cons of Humana Inc. in the next few years

Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Humana Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Humana Inc. -1.080% -6.376% -9.450% -24.098% -15.904% -60.238% -44.538%
Centene Corp. 1.390% -3.603% -0.287% -43.878% -45.575% -60.603% -46.350%
UnitedHealth Group Inc. -3.220% -1.196% -10.738% -50.905% -43.028% -44.367% -7.948%
Cigna Corp. -0.410% 1.421% -10.889% -24.663% -12.320% -21.925% 24.064%

Comments

Prediction Buy
Perf. (%) -16.26%
Target price 269.430
Change
Ends at 12.10.26

Humana (NYSE:HUM) had its price target raised by analysts at Wolfe Research from $283.00 to $313.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -19.58%
Target price 296.390
Change
Ends at 09.10.26

Humana (NYSE:HUM) was given a new $345.00 price target on by analysts at Mizuho. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -19.26%
Target price 296.616
Change
Ends at 07.10.26

Humana (NYSE:HUM) was given a new $347.00 price target on by analysts at Wells Fargo & Company. They now have an "overweight" rating on the stock.
Ratings data for HUM provided by MarketBeat
Show more

News

Humana Partners to Expand Mental Health Education for Louisville’s Next Generation
Humana Partners to Expand Mental Health Education for Louisville’s Next Generation


Following World Mental Health Day, the Humana Foundation – the philanthropic arm of Humana Inc. for the past 44 years – along with Jewish Heritage Fund and the University of Louisville’s Christina

Humana’s 2026 Medicare Advantage Plans Prioritize Simplicity, Stability and Quality Care for Beneficiaries
Humana’s 2026 Medicare Advantage Plans Prioritize Simplicity, Stability and Quality Care for Beneficiaries


Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026. During the Medicare Annual Election

New Research in a New England Journal of Medicine Publication Finds Patients of Value-Based Care Organizations Have More Frequent and Consistent Primary Care Visits
New Research in a New England Journal of Medicine Publication Finds Patients of Value-Based Care Organizations Have More Frequent and Consistent Primary Care Visits


A new study published in The New England Journal of Medicine Catalyst, conducted by the Humana Healthcare Research team and Massachusetts General Hospital Attending Physician Dr. Suhas Gondi, who